HIV/AIDS
Pharma firm reaches agreement with Brazilian government for AIDS drug
Published in AIDS Weekly, August 22nd, 2005
The agreement accomplishes Abbott's objectives of helping Brazil expand patient access to Kaletra while preserving the company's intellectual property rights, which Abbott was not willing to negotiate.
The agreement does not specify a per-capsule price, and will not be at the low price quoted for local and generic manufacturers. The price of Kaletra will be dependent on the number of patients treated.
Abbott agreed to provide assistance to Brazil to enable local...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-08-22)
More Articles from AIDS Weekly
- HIV/AIDS Coinfection
Neisseria gonorrhoeae enhances infection of dendritic cells by HIV-1 - HIV/AIDS Needlestick Injury
Postexposure practice inadequate in medical students with needlestick injury - HIV/AIDS Pathogenesis
Cultured myeloid dendritic cells from HIV patients fail to differentiate - HIV/AIDS Perinatal Transmission
Nevirapine resistance after single NVP dose higher in women with HIV-1 subtype C - HIV/AIDS Transmission
Incorporation of ABO antigens by HIV-1 may affect viral transmission - Awards
Stephen C. Harrison wins Bristol-Myers Squibb infectious diseases research award - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
